
(HealthDay News) – Moderna Inc. announced Wednesday that the revamped COVID booster shot it has developed to fight Omicron and its subvariants should be ready for public use by August. The company has been making shots of the vaccine, called mRNA-1273.214, before getting regulatory approval so it can be ready to ship doses out for… read on > read on >